Tennessee · 114th Regular Session (2025-2026) · Bill

SB 2549: Opioids - As enacted, adds that a healthcare provider who subcontracts through the contracted healthcare vendor with the department of correction may prescribe a buprenorphine product for the treatment of opioid use disorder if other certain listed criteria are met. - Amends TCA Title 53 and Title 63.

Enacted Last action April 13, 2026: Pub. Ch. 677

Plain-language summary

SB 2549 is a bill introduced in the Tennessee Senate on February 2, 2026. According to its official title, it concerns: Opioids - As enacted, adds that a healthcare provider who subcontracts through the contracted healthcare vendor with the department of correction may prescribe a buprenorphine product for the treatment of opioid use disorder if other certain listed criteria are met. - Amends TCA Title 53 and Title 63. Primary sponsor: Reeves. Most recent recorded action (April 13, 2026): Pub. Ch. 677.

Sponsors

Primary sponsor: Reeves.